#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I II – III refractory Adrenogenital syndrome Toxic epidermal necrolysis Von Hippel-Lindau disease B precursor type acute leukaemia Retinal artery occlusion Soft tissue necrosis Rett syndrome IPEX syndrome Dent's disease Congenital megacolon Bronchiolitis Chronic myelomonocytic leukaemia Non-small cell lung cancer metastatic Epilepsy with myoclonic-atonic seizures More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Hereditary optic atrophy – Basic Information Nephroblastoma – Treatment Adrenocortical carcinoma – Trials in Disease Hyperoxaluria – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Life with Disease Breast angiosarcoma metastatic Langerhans cell sarcoma – Diagnostics Cystic fibrosis lung – Diagnostics Hyperoxaluria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fosphenytoin Sodium [68GA]GA-NOTA-AE105 Donidalorsen Ag-946 Brimonidine Tartrate Iron Sucrose PRT3789 FRUQUINTINIB Aldesleukin Elranatamab Linsitinib Lactose Monohydrate Felis Domesticus (555) Vesleteplirsen AMODIAQUINE Oric-114 Ursodoxicoltaurine Corylus Avellana L. Hydrochlorothiazide Rilzabrutinib More therapies…

    Learn about Your Condition

    Retinal vein occlusion Rosai-Dorfman syndrome Macular oedema Neurotrophic keratopathy Septic shock Kaposi's sarcoma Dermatitis Alport's syndrome Paresis Pelvic venous thrombosis Craniosynostosis Lennox-Gastaut syndrome Pleomorphic leiomyosarcoma Anaemia of pregnancy Colon cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gesundheit Nordhessen Holding AG

Gesundheit Nordhessen Holding AG

Mönchebergstr. 41-43, Kassel, 34125, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Melphalan
    • Busulfan
    Austria Belgium Czechia Denmark Finland France +11

  • Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Dactinomycin
    • Carboplatin
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Propylene Glycol
    • Bevacizumab
    Belgium Bulgaria Czechia France Germany Greece +5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!